338 related articles for article (PubMed ID: 25974157)
1. Non-steroidal anti-inflammatory drugs and the risk of head and neck cancer: A case-control analysis.
Becker C; Wilson JC; Jick SS; Meier CR
Int J Cancer; 2015 Nov; 137(10):2424-31. PubMed ID: 25974157
[TBL] [Abstract][Full Text] [Related]
2. Metformin and the risk of head and neck cancer: a case-control analysis.
Becker C; Jick SS; Meier CR; Bodmer M
Diabetes Obes Metab; 2014 Nov; 16(11):1148-54. PubMed ID: 25041125
[TBL] [Abstract][Full Text] [Related]
3. Non-steroidal anti-inflammatory drug and aspirin use and the risk of head and neck cancer.
Wilson JC; Murray LJ; Hughes CM; Black A; Anderson LA
Br J Cancer; 2013 Mar; 108(5):1178-81. PubMed ID: 23449358
[TBL] [Abstract][Full Text] [Related]
4. Non-steroidal anti-inflammatory drug and aspirin use and the risk of head and neck cancer: a systematic review.
Wilson JC; Anderson LA; Murray LJ; Hughes CM
Cancer Causes Control; 2011 May; 22(5):803-10. PubMed ID: 21409528
[TBL] [Abstract][Full Text] [Related]
5. Nonsteroidal anti-inflammatory drugs and the risk of nonmelanoma skin cancer.
Reinau D; Surber C; Jick SS; Meier CR
Int J Cancer; 2015 Jul; 137(1):144-53. PubMed ID: 25418602
[TBL] [Abstract][Full Text] [Related]
6. Association of nonsteroidal anti-inflammatory drugs and aspirin use and the risk of head and neck cancers: a meta-analysis of observational studies.
Tang L; Hu H; Liu H; Jian C; Wang H; Huang J
Oncotarget; 2016 Oct; 7(40):65196-65207. PubMed ID: 27533449
[TBL] [Abstract][Full Text] [Related]
7. Use of nonaspirin nonsteroidal anti-inflammatory drugs and risk of head and neck cancer: A nationwide case-control study.
de la Cour CD; Dehlendorff C; Aalborg GL; von Buchwald C; Friis S; Verdoodt F; Kjaer SK
Int J Cancer; 2020 Apr; 146(8):2139-2146. PubMed ID: 31265123
[TBL] [Abstract][Full Text] [Related]
8. Protective effects of metformin, statins and anti-inflammatory drugs on head and neck cancer: A systematic review.
Saka Herrán C; Jané-Salas E; Estrugo Devesa A; López-López J
Oral Oncol; 2018 Oct; 85():68-81. PubMed ID: 30220322
[TBL] [Abstract][Full Text] [Related]
9. Oral lesions, chronic diseases and the risk of head and neck cancer.
Li S; Lee YC; Li Q; Chen CJ; Hsu WL; Lou PJ; Zhu C; Pan J; Shen H; Ma H; Cai L; He B; Wang Y; Zhou X; Ji Q; Zhou B; Wu W; Ma J; Boffetta P; Zhang ZF; Dai M; Hashibe M
Oral Oncol; 2015 Dec; 51(12):1082-7. PubMed ID: 26526128
[TBL] [Abstract][Full Text] [Related]
10. Nonsteroidal anti-inflammatory drug use and breast cancer risk by stage and hormone receptor status.
Marshall SF; Bernstein L; Anton-Culver H; Deapen D; Horn-Ross PL; Mohrenweiser H; Peel D; Pinder R; Purdie DM; Reynolds P; Stram D; West D; Wright WE; Ziogas A; Ross RK
J Natl Cancer Inst; 2005 Jun; 97(11):805-12. PubMed ID: 15928301
[TBL] [Abstract][Full Text] [Related]
11. Low-dose aspirin use and risk of head and neck cancer-A Danish nationwide case-control study.
de la Cour CD; Verdoodt F; Aalborg GL; von Buchwald C; Friis S; Dehlendorff C; Kjaer SK
Br J Clin Pharmacol; 2021 Mar; 87(3):1561-1567. PubMed ID: 32737902
[TBL] [Abstract][Full Text] [Related]
12. Regular recreational physical activity and risk of head and neck cancer.
Lin CL; Lee WT; Ou CY; Hsiao JR; Huang CC; Huang JS; Wong TY; Chen KC; Tsai ST; Fang SY; Huang TT; Wu JL; Wu YH; Hsueh WT; Yen CJ; Lai YH; Liao HC; Wu SY; Yang MW; Lin FC; Chang JY; Wang YH; Weng YL; Yang HC; Chen YS; Chang JS
BMC Cancer; 2017 Apr; 17(1):286. PubMed ID: 28431509
[TBL] [Abstract][Full Text] [Related]
13. Nonsteroidal antiinflammatory drugs and the risk of myocardial infarction in the general population.
García Rodríguez LA; Varas-Lorenzo C; Maguire A; González-Pérez A
Circulation; 2004 Jun; 109(24):3000-6. PubMed ID: 15197149
[TBL] [Abstract][Full Text] [Related]
14. Nonsteroidal anti-inflammatory drugs and risk of lung cancer.
Hernández-Díaz S; García Rodríguez LA
Int J Cancer; 2007 Apr; 120(7):1565-72. PubMed ID: 17205530
[TBL] [Abstract][Full Text] [Related]
15. Nonsteroidal anti-inflammatory drugs and risk of Parkinson's disease.
Ton TG; Heckbert SR; Longstreth WT; Rossing MA; Kukull WA; Franklin GM; Swanson PD; Smith-Weller T; Checkoway H
Mov Disord; 2006 Jul; 21(7):964-9. PubMed ID: 16550541
[TBL] [Abstract][Full Text] [Related]
16. Breast cancer and nonsteroidal anti-inflammatory drugs: prospective results from the Women's Health Initiative.
Harris RE; Chlebowski RT; Jackson RD; Frid DJ; Ascenseo JL; Anderson G; Loar A; Rodabough RJ; White E; McTiernan A;
Cancer Res; 2003 Sep; 63(18):6096-101. PubMed ID: 14522941
[TBL] [Abstract][Full Text] [Related]
17. Non-steroidal anti-inflammatory drug use and essential tremor.
Pan J; Michalec M; Louis ED
Neuroepidemiology; 2014; 43(2):145-9. PubMed ID: 25376662
[TBL] [Abstract][Full Text] [Related]
18. Association of frequency and duration of aspirin use and hormone receptor status with breast cancer risk.
Terry MB; Gammon MD; Zhang FF; Tawfik H; Teitelbaum SL; Britton JA; Subbaramaiah K; Dannenberg AJ; Neugut AI
JAMA; 2004 May; 291(20):2433-40. PubMed ID: 15161893
[TBL] [Abstract][Full Text] [Related]
19. The risk of acute major upper gastrointestinal bleeding among users of aspirin and ibuprofen at various levels of alcohol consumption.
Kaufman DW; Kelly JP; Wiholm BE; Laszlo A; Sheehan JE; Koff RS; Shapiro S
Am J Gastroenterol; 1999 Nov; 94(11):3189-96. PubMed ID: 10566713
[TBL] [Abstract][Full Text] [Related]
20. Breast cancer and use of nonsteroidal anti-inflammatory drugs: a meta-analysis.
Takkouche B; Regueira-Méndez C; Etminan M
J Natl Cancer Inst; 2008 Oct; 100(20):1439-47. PubMed ID: 18840819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
